Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Bristol-Myers Squibb Co (NYSE:BMY)

64.18
Delayed Data
As of Oct 17
 +0.53 / +0.83%
Today’s Change
46.01
Today|||52-Week Range
66.10
+9.82%
Year-to-Date

Today’s Trading

Previous close63.65
Today’s open63.63
Day’s range63.41 - 64.37
Volume5,030,781
Average volume (3 months)6,333,429
Market cap$104.4B
Dividend yield2.43%
Data as of 4:00pm ET, 10/17/2017

Growth & Valuation

Earnings growth (last year)+184.95%
Earnings growth (this year)+5.36%
Earnings growth (next 5 years)+9.81%
Revenue growth (last year)+17.31%
P/E ratio23.4
Price/Sales5.05
Price/Book6.55

Competitors

 Today’s
change
Today’s
% change
GSKGlaxoSmithKline-0.03-0.07%
NVONovo Nordisk-0.01-0.02%
CELGCelgene+2.15+1.57%
ABTAbbott Laboratories+0.43+0.79%
Data as of 4:02pm ET, 10/17/2017

Financials

Next reporting dateOctober 26, 2017
EPS forecast (this quarter)$0.76
Annual revenue (last year)$19.4B
Annual profit (last year)$4.5B
Net profit margin22.94%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
Chairman &
Chief Executive Officer
Giovanni Caforio
CFO, EVP &
Head-Global Business Operations
Charles A. Bancroft
Corporate headquarters
New York, New York

Forecasts